SCHMID Group reported a strong third quarter in 2026 with order intake more than doubling to €67.8 million, driven by a repeat order exceeding €37 million. Revenues for Q3 reached €24 million, with a nine-month total of €70 million. The company raised its full-year order intake guidance to over €150 million, up from an earlier range of €125-150 million, while maintaining revenue guidance above €100 million and an adjusted EBITDA margin of 6-9%. A significant new order supporting HDI manufacturing expansion in Malaysia also contributes to continued momentum into Q4.
SCHMID Group's third quarter 2026 business update provides context for industrial sector activity. For readers following Industrials, here is Pluang's market snapshot as of Oct 21, 2026 15:21 WIB: Among 135 priced Industrials-sector US stocks tradable on Pluang, 83 rose and 45 fell today. Notable movers include SPCX (SpaceX) at USD 161.66 with a 1-day change of +9.38% and Pluang order activity of 41% Sell / 59% Buy, BE (Bloom Energy) at USD 234.22 with +5.20% and 21% Sell / 79% Buy, and VRT (Vertiv Holdings Co) at USD 211.89 with +4.09% and 20% Sell / 80% Buy.
The Human Feedback Foundation, supported by RBC, has launched the Agentic AI Design Exchange, a national program aimed at helping Canadian nonprofits design, build, and deploy AI agents responsibly. Funded through RBC's Stronger Nonprofits Program, t...
Satellos Bioscience Inc., a clinical-stage company focused on treatments for degenerative muscle diseases, announced its management will participate in two investor conferences in November: the Guggenheim Healthcare Innovation Conference on Nov 9 in ...
YYForce Inc. has purchased 20 wearable data collection systems to gather real task data from hotel room service at Novotel Singapore. This project aims to record and analyze experienced staff performing tasks like bed-making, towel folding, and clean...
The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, at a compound annual growth rate of 20.2%. This growth is driven by increasing demand for chronic disease managem...
The global private credit and alternative lending market, valued at $2.31 trillion in 2026, is expected to grow at a 7.8% CAGR to reach $3.36 trillion by 2031. Recent liquidity pressures in 2025, triggered by bankruptcies and AI sector concerns, caus...
